Peptide Skincare & BeautySkin science and ingredient guides

Ingredient or product comparison

Delivery Routes: Subcutaneous vs Topical Bioavailability

GHK-Cu can be administered subcutaneously, topically, or orally. For women 25-35 prioritising systemic collagen support. Not just facial skin. Subcutaneous injection delivers measurably higher bioavailability. The peptide survives gastric degradation poorly, s

This source-based comparison does not add ratings or recommend a winner.

  • GHK-Cu can be administered subcutaneously, topically, or orally. For women 25-35 prioritising systemic collagen support. Not just facial skin. Subcutaneous injection delivers measurably higher bioavailability. The peptide survives gastric degradation poorly, so oral supplementation is generally ineffective unless using a liposomal formulation (which increases cost substantially). Topical application works for localized facial benefits but won't address connective tissue throughout the body.
  • Subcutaneous injection bypasses first-pass metabolism entirely. Administered into abdominal or thigh subcutaneous fat, GHK-Cu enters systemic circulation within 15–20 minutes and reaches peak plasma concentration within 45 minutes. The copper-peptide complex remains stable long enough to reach target tissues. Skin, fascia, tendons, and vascular endothelium. Before hepatic clearance. Studies using radiolabeled GHK-Cu demonstrated distribution to collagen-rich tissues within two hours of subcutaneous administration, with peak activity in dermal fibroblasts occurring 6–8 hours post-injection.
  • Topical formulations penetrate the stratum corneum if molecular weight is kept below 500 Daltons (GHK-Cu is 340 Da) and the vehicle includes penetration enhancers like DMSO or liposomal carriers. A 2% GHK-Cu serum applied nightly to clean skin delivers localized benefits to the epidermis and upper dermis but doesn't achieve systemic levels. For women 25-35 focused exclusively on facial skin quality, topical may suffice. For those seeking broader connective tissue support. Improved joint recovery, tendon resilience, or overall skin elasticity beyond the face. Subcutaneous administration is the evidence-backed choice.
  • One critical preparation detail most guides skip: reconstitution solvent matters. GHK-Cu lyophilized powder must be reconstituted with bacteriostatic water, not sterile water. Bacteriostatic water contains 0.9% benzyl alcohol, which prevents bacterial growth in multi-dose vials and extends stability. Once reconstituted, store the vial at 2–8°C (refrigerated) and use within 28 days. A vial stored at room temperature for more than 48 hours loses approximately 30% potency due to peptide degradation. This isn't theoretical. Stability assays confirm it. Clients who report 'the peptide stopped working' after week three often stored it improperly.